Ou S, Nie X, Qiu X, Jin X, Wu G, Zhang R
Cell Death Discov. 2025; 11(1):14.
PMID: 39827195
PMC: 11743196.
DOI: 10.1038/s41420-025-02290-6.
Mehra N, Sundaram S, Shah P, Rao A
Curr Oncol Rep. 2025; 27(1):37-44.
PMID: 39776330
DOI: 10.1007/s11912-024-01623-5.
Stepanyan A, Brojakowska A, Zakharyan R, Hakobyan S, Davitavyan S, Sirunyan T
Cardiovasc Diabetol. 2024; 23(1):454.
PMID: 39732652
PMC: 11682651.
DOI: 10.1186/s12933-024-02565-9.
Park S, Lee H
Brief Bioinform. 2024; 25(6).
PMID: 39550222
PMC: 11568879.
DOI: 10.1093/bib/bbae586.
Shi K, Wang X, Huang L, Guo Q, Yuan W, Lv Y
Heliyon. 2024; 10(21):e38490.
PMID: 39512466
PMC: 11539247.
DOI: 10.1016/j.heliyon.2024.e38490.
Metal-free synthesis of N-fused quinazolino-quinazoline-diones as a RNA triple helix intercalator.
Pathi V, Das P, Guin A, Debnath M, Banerji B
RSC Med Chem. 2024; .
PMID: 39507616
PMC: 11537285.
DOI: 10.1039/d4md00614c.
Autophagy in oral cancer: Promises and challenges (Review).
Li Z, Zhang Y, Lei J, Wu Y
Int J Mol Med. 2024; 54(6).
PMID: 39422076
PMC: 11518578.
DOI: 10.3892/ijmm.2024.5440.
Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.
Zhang X, Zhang Y, Liu Q, Zeng A, Song L
Front Immunol. 2024; 15:1456636.
PMID: 39346921
PMC: 11437524.
DOI: 10.3389/fimmu.2024.1456636.
Nrf2 in human cancers: biological significance and therapeutic potential.
Tian Y, Tang L, Wang X, Ji Y, Tu Y
Am J Cancer Res. 2024; 14(8):3935-3961.
PMID: 39267682
PMC: 11387866.
DOI: 10.62347/LZVO6743.
Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy.
Wang T, Li Q, Xu R, Zhao Z, Sun Q, Xu X
Front Pharmacol. 2024; 15:1437071.
PMID: 39139640
PMC: 11319142.
DOI: 10.3389/fphar.2024.1437071.
Personalizing Therapy Outcomes through Mitogen-Activated Protein Kinase Pathway Inhibition in Non-Small Cell Lung Cancer.
Alsharoh H, Chiroi P, Isachesku E, Tanasa R, Pop O, Pirlog R
Biomedicines. 2024; 12(7).
PMID: 39062063
PMC: 11275062.
DOI: 10.3390/biomedicines12071489.
Coding, or non-coding, that is the question.
Poliseno L, Lanza M, Pandolfi P
Cell Res. 2024; 34(9):609-629.
PMID: 39054345
PMC: 11369213.
DOI: 10.1038/s41422-024-00975-8.
Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths.
Hjazi A, Jasim S, Altalbawy F, Kaur H, Hamzah H, Kaur I
Cell Biochem Biophys. 2024; 82(3):1613-1627.
PMID: 38806965
DOI: 10.1007/s12013-024-01317-6.
Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells.
Lee P, Koseki L, Haitani T, Harada H, Kobayashi M
Cancers (Basel). 2024; 16(9).
PMID: 38730681
PMC: 11083728.
DOI: 10.3390/cancers16091729.
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.
Liu J, Yang F, Hu J, Zhang X
CNS Neurosci Ther. 2024; 30(5):e14715.
PMID: 38708806
PMC: 11071172.
DOI: 10.1111/cns.14715.
: A Long Non-Coding RNA with Multiple Functions and Its Role in Processes Associated with Fat Deposition.
Piorkowska K, Zygmunt K, Hunter W, Wroblewska K
Genes (Basel). 2024; 15(4).
PMID: 38674413
PMC: 11049917.
DOI: 10.3390/genes15040479.
Evaluation of the clinical significance of long non-coding RNA genetic variants in human lung adenocarcinoma.
Lin S, Lu J, Hsieh W, Chou Y, Su T, Tsai T
Aging (Albany NY). 2024; 16(6):5740-5750.
PMID: 38517388
PMC: 11006483.
DOI: 10.18632/aging.205675.
MALAT-1 Is a Key Regulator of Epithelial-Mesenchymal Transition in Cancer: A Potential Therapeutic Target for Metastasis.
Hussein M, Valinezhad K, Adel E, Munirathinam G
Cancers (Basel). 2024; 16(1).
PMID: 38201661
PMC: 10778055.
DOI: 10.3390/cancers16010234.
Deep Conservation and Unexpected Evolutionary History of Neighboring lncRNAs MALAT1 and NEAT1.
Weghorst F, Torres Marcen M, Faridi G, Lee Y, Cramer K
J Mol Evol. 2024; 92(1):30-41.
PMID: 38189925
PMC: 10869381.
DOI: 10.1007/s00239-023-10151-y.
The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma.
Anbiyaee O, Moalemnia A, Ghaedrahmati F, Khombi Shooshtari M, Khoshnam S, Kempisty B
BMC Nephrol. 2023; 24(1):380.
PMID: 38124072
PMC: 10731893.
DOI: 10.1186/s12882-023-03438-1.